跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MED-LATANOPROST-TIMOLOL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MED-LATANOPROST-TIMOLOL
Authorized
STANDARD
MED-LATANOPROST-TIMOLOL
generic medical partners inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
34c5b93fd8083fbf
Company
generic medical partners inc
Type
Standard
Approval Details
Approval Id
34c5b93fd8083fbf
Drug Approval Canada Name
MED-LATANOPROST-TIMOLOL
Product Name
MED-LATANOPROST-TIMOLOL
Status
Marketed
Status Date
2019-08-22
Original Market Date
2019-08-22
Din
02454505
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:40.28
Atc Original
S01ED51 TIMOLOL, COMBINATIONS
Atc Name
s 01 ed 51
Aig Number
0248501001
Company Name
generic medical partners inc
Company Address
1500 Don Mills Road, Suite 711, Toronto, Ontario, Canada, M3B 3K4
Active Ingredients
LATANOPROST
50 MCG / ML
TIMOLOL (TIMOLOL MALEATE)
5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
34c5b93fd8083fbf
Type
Standard
Back to Health Canada Approvals